Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia

被引:19
|
作者
Kim, Melissa M. [1 ]
Conyngham, S. Caitlin [1 ]
Smith, Champagnae [1 ]
Higgins, Dana [1 ]
Nassau, Tanner [1 ]
Terrell, Coleman [1 ]
Brady, Kathleen A. [1 ]
机构
[1] Philadelphia Dept Publ Hlth, 1101 Market St,Eighth Floor, Philadelphia, PA 19107 USA
来源
关键词
Outbreak Response; PWID; Social Determinants of Health; Opioid epidemic; HIV Surveillance; SYRINGE EXCHANGE; HIV-INFECTION; USERS; HOMELESSNESS; DIAGNOSES; PROGRAMS; PEOPLE;
D O I
10.1093/infdis/jiaa128
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. In 2018, Philadelphia identified an outbreak of new human immunodeficiency virus (HIV) infections among persons who inject drugs (PWID). Although conventional HIV surveillance systems capture individual-level behavioral risk, they are not able to capture the social and environmental factors contributing to rapid transmission. Methods. HIV surveillance data were used to assess demographic, clinical, and behavioral factors for PWID with HIV diagnosed during 2017 and 2018. Social factors such as homelessness, disruption of encampments, and trends in sexual behaviors, drug use and syringe availability among PWID were captured through National HIV Behavioral Surveillance, routine hepatitis and sexually transmitted infection surveillance, and shelter and homeless outreach data. Results. In 2018, there were 71 new infections among PWID, an increase of 115% since 2016. During this time, opioid overdose deaths peaked at 59 deaths per 100 000 persons, 85% of which involved the use of fentanyl. While overall reported homelessness increased, rates of those living unsheltered rose by 13%. The Philadelphia Department of Public Health identified increased injection frequency, encampment closures, and lack of syringe access as promoters of continued HIV transmission. Conclusion. The use of conventional surveillance methods only is inadequate for determining HIV risk during outbreaks. Incorporation of individual and aggregate level data on social and environmental determinants is necessary to develop effective outbreak response interventions.
引用
收藏
页码:S250 / S258
页数:9
相关论文
共 50 条
  • [31] Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study
    Haya Altawalah
    Sahar Essa
    Sayeh Ezzikouri
    Widad Al-Nakib
    Scientific Reports, 9
  • [32] Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study
    Altawalah, Haya
    Essa, Sahar
    Ezzikouri, Sayeh
    Al-Nakib, Widad
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [33] Centering persons who use drugs: addressing social determinants of health among patients hospitalized with substance use disorders
    Roberts, Kate
    Smith, Emily
    Sousa, Cindy
    Young, J. Elaina
    Corley, Anna Grace
    Szczotka, Darin
    Sepanski, Abby
    Hartoch, Ashley
    SOCIAL WORK IN HEALTH CARE, 2024, 63 (01) : 19 - 34
  • [34] Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey
    Siyan Yi
    Phalkun Mun
    Pheak Chhoun
    Navy Chann
    Sovannary Tuot
    Gitau Mburu
    Harm Reduction Journal, 16
  • [35] Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey
    Yi, Siyan
    Mun, Phalkun
    Chhoun, Pheak
    Chann, Navy
    Tuot, Sovannary
    Mburu, Gitau
    HARM REDUCTION JOURNAL, 2019, 16 (1)
  • [36] Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico
    Meacham, Meredith C.
    Roesch, Scott C.
    Strathdee, Steffanie A.
    Lindsay, Suzanne
    Gonzalez-Zuniga, Patricia
    Gaines, Tommi L.
    DRUG AND ALCOHOL REVIEW, 2018, 37 (01) : 128 - 136
  • [37] Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015
    Abara, Winston E.
    Trujillo, Lindsay
    Broz, Dita
    Finlayson, Teresa
    Teshale, Eyasu
    Paz-Bailey, Gabriela
    Glick, Sara
    Al-Tayyib, Alia A.
    Robinson, William T.
    Masiello-Schuette, Stephanie
    Sey, Ekow K.
    Anderson, Bridget J.
    Poe, Jonathon
    Braunstein, Sarah
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (03): : 377 - 385
  • [38] Limited Risk Compensation Among Women Who Inject Drugs: Results From the Project Sexual Health Equity Preexposure Prophylaxis Demonstration Study in Philadelphia
    Tran, Nguyen K.
    van der Pol, Barbara
    Shrestha, Roman
    Bazzi, Angela R.
    Bellamy, Scarlett L.
    Sherman, Susan G.
    Roth, Alexis M.
    SEXUALLY TRANSMITTED DISEASES, 2022, 49 (05) : E64 - E66
  • [39] The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015
    Nassau, Tanner
    Al-Tayyib, Alia
    Robinson, William T.
    Shinefield, Jennifer
    Brady, Kathleen A.
    PUBLIC HEALTH REPORTS, 2020, 135 (1_SUPPL) : 138S - 148S
  • [40] Pneumococcal disease among human immunodeficiency virus-infected persons: Incidence, risk factors, and impact of vaccination
    Dworkin, MS
    Ward, JW
    Hanson, DL
    Jones, JL
    Kaplan, JE
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 794 - 800